Article
RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases.
Annals of surgical oncology - 1 Mar 2015
Zimmitti Giuseppe, Shindoh Junichi, Mise Yoshihiro, Kopetz Scott, Loyer Evelyne M, Andreou Andreas, Cooper Amanda B, Kaur Harmeet, Aloia Thomas A, Maru Dipen M, Vauthey Jean-Nicolas
Abstract excerpt
BACKGROUND: RAS mutations have been reported to be a potential prognostic factor in patients with colorectal liver metastases (CLM). However, the impact of RAS mutations on response to chemotherapy remains unclear. The purpose of this study was to investigate the correlation between RAS mutations and response to preoperative chemotherapy and their impact on survival in patients undergoing curative resection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
